Cargando…

Fgl2: link between hepatitis B and SARS?

A new clotting factor protein, FGL2/fibroleukin, has been found to be important in viral infection, including hepatitis B. A greater understanding of this protein could offer a novel method for intervention and treatment for patients with viral hepatitis.

Detalles Bibliográficos
Autor principal:	Robertson, Morag
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Science Ltd. 2003
Materias:	Update
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7129602/ https://www.ncbi.nlm.nih.gov/pubmed/12946632 http://dx.doi.org/10.1016/S1359-6446(03)02836-8

Ejemplares similares

The Role of FGL2 in the Pathogenesis and Treatment of Hepatitis C Virus Infection
por: Shalev, Itay, et al.
Publicado: (2010)

Neuropsychiatric disorders following SARS-CoV-2 infection
por: Harrison, Paul J, et al.
Publicado: (2023)

Schweres akutes respiratorisches Syndrom (SARS)
por: Hoheisel, Gerhard, et al.
Publicado: (2006)

Targeting FGL2 in glioma immunosuppression and malignant progression
por: Ma, Xiaoyu, et al.
Publicado: (2022)

Identification of the Receptor for FGL2 and Implications for Susceptibility to Mouse Hepatitis Virus (MHV-3)-Induced Fulminant Hepatitis
por: Liu, Hao, et al.
Publicado: (2006)

Clinical efficacy of iodine complex in SARS-CoV-2-infected patients with mild to moderate symptoms: study protocol for a randomized controlled trial
por: Ashraf, Sohaib, et al.
Publicado: (2022)

Corneal cross-linking versus standard care in children with keratoconus – a randomised, multicentre, observer-masked trial of efficacy and safety (KERALINK): a statistical analysis plan
por: Chowdhury, Kashfia, et al.
Publicado: (2020)

A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the Remote Early Detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial
por: Brakenhoff, Timo B., et al.
Publicado: (2021)

sFgl2 gene-modified MSCs regulate the differentiation of CD4(+) T cells in the treatment of autoimmune hepatitis
por: Ji, Wenbin, et al.
Publicado: (2023)

LAMP2: a major update of the database linking antimicrobial peptides
por: Ye, Guizi, et al.
Publicado: (2020)

Safety and efficacy of belimumab after B cell depletion therapy in systemic LUPUS erythematosus (BEAT-LUPUS) trial: statistical analysis plan
por: Muller, Patrick, et al.
Publicado: (2020)

Statistical analysis plan for the POLAR-RCT: The Prophylactic hypOthermia trial to Lessen trAumatic bRain injury-Randomised Controlled Trial
por: Presneill, Jeffrey, et al.
Publicado: (2018)

Dual immunological and proliferative regulation of immune checkpoint FGL1 in lung adenocarcinoma: The pivotal role of the YY1–FGL1–MYH9 axis
por: Tang, Xi-Yang, et al.
Publicado: (2022)

Barriers impacting the POINT pragmatic trial: the unavoidable overlap between research and intervention procedures in “real-world” research
por: Dir, Allyson L., et al.
Publicado: (2021)

SARS-CoV-2 and Fetal Inflammation
Publicado: (2022)

Treatment of Middle East respiratory syndrome with a combination of lopinavir/ritonavir and interferon-β1b (MIRACLE trial): statistical analysis plan for a recursive two-stage group sequential randomized controlled trial
por: Arabi, Yaseen M., et al.
Publicado: (2020)

sFgl2-Treg Positive Feedback Pathway Protects against Atherosclerosis
por: An, Tianhui, et al.
Publicado: (2023)

Pragmatic cluster randomized trial to evaluate effectiveness and implementation of EHR-facilitated collaborative symptom control in cancer (E2C2): addendum
por: Herrin, Jeph, et al.
Publicado: (2023)

Updates of incretin‐related drugs for the treatment of type 2 diabetes
por: Araki, Hirotaka, et al.
Publicado: (2022)

A Convenient Synthetic Protocol to 1,2-Bis(dialkylphosphino)ethanes
por: Doyle, Laurence R, et al.
Publicado: (2014)

THE MISSING LINK IN THE HISTORY OF THE LOCKED INTRAMEDULLARY NAIL
por: CAMARGO, FLÁVIO PIRES DE, et al.
Publicado: (2021)

The era of continuous glucose monitoring and its expanded role in type 2 diabetes
por: Yu, Jin, et al.
Publicado: (2023)

Diet and exercise are a fundamental part of comprehensive care for type 2 diabetes
por: Yeh, Yun Kai, et al.
Publicado: (2023)

Platelet-rich plasma in Achilles tendon healing 2 (PATH-2) trial: statistical analysis plan for a multicentre, double-blinded, parallel-group, placebo-controlled randomised clinical trial
por: Schlüssel, Michael M., et al.
Publicado: (2018)

A new era of diabetic kidney disease treatment with sodium–glucose cotransporter‐2 inhibitors
por: Kume, Shinji, et al.
Publicado: (2022)

Progressive exercise compared with best practice advice, with or without corticosteroid injection, for the treatment of rotator cuff disorders: statistical analysis plan for the Getting it Right: Addressing Shoulder Pain (GRASP) 2 × 2 factorial multicentre randomised controlled trial
por: Marian, Ioana R., et al.
Publicado: (2020)

Palladium-Catalyzed Synthesis of 2,3-Disubstituted Benzofurans: An Approach Towards the Synthesis of Deuterium Labeled Compounds
por: Agasti, Soumitra, et al.
Publicado: (2015)

Statistical analysis plan for the ‘Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage’ (TICH-2) trial
por: Flaherty, Katie, et al.
Publicado: (2017)

Transfusion Indication Threshold Reduction (TITRe2) randomized controlled trial in cardiac surgery: statistical analysis plan
por: Pike, Katie, et al.
Publicado: (2015)

Keeping up with the guidelines: design changes to the STREAM stage 2 randomised controlled non-inferiority trial for rifampicin-resistant tuberculosis
por: Goodall, Ruth L., et al.
Publicado: (2022)

FGL2–MCOLN3-Autophagy Axis–Triggered Neutrophil Extracellular Traps Exacerbate Liver Injury in Fulminant Viral Hepatitis
por: Li, Xitang, et al.
Publicado: (2022)

Serial prophylactic exchange blood transfusion in pregnant women with sickle cell disease (TAPS-2): statistical and qualitative analysis plan for a randomised controlled feasibility trial
por: Seed, Paul T., et al.
Publicado: (2023)

Statistical analysis plan for a cluster randomised trial in Madhya Pradesh, India: support to rural India’s public education system and impact on numeracy and literacy scores (STRIPES2)
por: Keddie, Suzanne, et al.
Publicado: (2023)

NAVKIDS(2) trial: a multi-centre, waitlisted randomised controlled trial of a patient navigator intervention in children with chronic kidney disease — statistical analysis plan and update to the protocol
por: van Zwieten, Anita, et al.
Publicado: (2022)

Community participatory learning and action cycle groups to reduce type 2 diabetes in Bangladesh (D:Clare): an updated study protocol for a parallel arm cluster randomised controlled trial
por: King, Carina, et al.
Publicado: (2023)

Immune Checkpoint LAG3 and Its Ligand FGL1 in Cancer
por: Shi, An-Ping, et al.
Publicado: (2022)

Dynamics of Functionally Graded Laminated (FGL) Media—Theoretical Tolerance Modelling
por: Jędrysiak, Jarosław
Publicado: (2023)

Update on the General Practice Optimising Structured Monitoring to Improve Clinical Outcomes in Type 2 Diabetes (GP-OSMOTIC) trial: statistical analysis plan for a multi-centre randomised controlled trial
por: Thuraisingam, Sharmala, et al.
Publicado: (2019)

Statistical analysis plan for the Dex-CSDH trial: a randomised, double-blind, placebo-controlled trial of a 2-week course of dexamethasone for adult patients with a symptomatic chronic subdural haematoma
por: Allison, Annabel, et al.
Publicado: (2019)

FGL2 is positively correlated with enhanced antitumor responses mediated by T cells in lung adenocarcinoma
por: Yuan, Kai, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_v4e6gjdhjtq61rmdmcs8d3f8cf